Showing results (131-140 of 1,759) with videos related to
Sort By:
Pageof 176
Cellular & Molecular Immunology|October 30, 2024
Specific ECM degradation potentiates the antitumor activity of CAR-T cells in solid tumorsRui Zheng, Kuo Shen, Sixin Liang, et al.Cellular & Molecular Immunology|October 15, 2024
Immunotherapy for glioblastoma: current state, challenges, and future perspectivesYang Liu, Fei Zhou, Heba Ali, et al.Cellular & Molecular Immunology|October 22, 2024
Ubiquitin regulatory X (UBX) domain-containing protein 6 is essential for autophagy induction and inflammation control in macrophagesYoung Jae Kim, Sung-Gwon Lee, So Young Park, et al.Cellular & Molecular Immunology|November 8, 2024
Targeting of TAMs: can we be more clever than cancer cells?Julia Kzhyshkowska, Jiaxin Shen, Irina LarionovaCellular & Molecular Immunology|March 3, 2025
Cholesterol homeostasis and lipid raft dynamics at the basis of tumor-induced immune dysfunction in chronic lymphocytic leukemiaChaja F Jacobs, Fleur S Peters, Elena Camerini, et al.Cellular & Molecular Immunology|February 12, 2025
γδ T-cell autoresponses to ectopic membrane proteins: a new type of pattern recognitionHongqin You, Xiangjin Zhang, Hui Chen, et al.Cellular & Molecular Immunology|August 12, 2024
Immune surveillance of cytomegalovirus in tissuesAndrea Mihalić, Jelena Železnjak, Berislav Lisnić, et al.Cellular & Molecular Immunology|August 12, 2024
IL-33 released during challenge phase regulates allergic asthma in an age-dependent wayHangyu Liu, Min Wu, Qiangqiang Wang, et al.Cellular & Molecular Immunology|June 25, 2024
Innate and adaptive immune responses that control lymph-borne viruses in the draining lymph nodeCarolina R Melo-Silva, Luis J SigalCellular & Molecular Immunology|September 19, 2006
The molecular mechanism of HDAC inhibitors in anticancer effectsGaofeng Bi, Guosheng JiangPageof 176